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Abstract
Background: Control measures which reduce individual exposure to malaria are expected to reduce disease, but also to
eventually reduce immunity. Reassuringly, long term data following community wide ITN distribution show sustained
benefits at a population level. However, the more common practice in Sub-Saharan Africa is to target ITN distribution on
young children. There are few data on the long term outcomes of this practice.
Methodology/Principal Findings: Episodes of febrile malaria were identified by active surveillance in 383 children over 18
months of follow up. In order to compare the short and long term outcomes of ITN use, we examined interactions between
ITN use and age (12–42 months of age versus 42–80 months) in determining the risk of febrile malaria. ITN use and older
age protected against the first or only episode of malaria (Hazard Ratio [HR] =0.33, 95%CI 0.17–0.65 and HR =0.30, 95%CI
0.17–0.51, respectively). The interaction term between ITN use and older age was HR =2.91, 95%CI 1.02–8.3, p=0.045,
indicating that ITNs did not protect older children. When multiple episodes were included in analysis, ITN use and older age
were again protective against malaria episodes (Incident Rate Ratio [IRR] =0.43 95%CI 0.27–0.7) and IRR =0.23, 95%CI 0.13–
0.42, respectively) and the interaction term indicated that ITNs did not protect older children (IRR =2.71, 95%CI 1.3–5.7,
p=0.008).
Conclusions/Significance: These data on age interactions with ITN use suggest that larger scale studies on the long term
individual outcomes should be undertaken if the policy of targeted ITN use for vulnerable groups is to continue.
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Introduction
Malaria is a global public health problem. There were over 500
million episodes globally in 2002, and over a million deaths in
Africa [1,2]. The evidence that insecticide treated nets (ITNs)
reduce malaria risk and mortality is overwhelming [3]. Recently,
ITN distribution has become more widespread in some endemic
countries [4] with reductions in childhood mortality [5].
The relationship between malaria transmission and morbidity/
mortality is not linear [6], perhaps because acquiring immunity at
an earlier age under high transmission conditions offsets the
overall increase in life time cases of malaria one might expect to
see. Hence, the average age of children with severe malaria
increases as transmission falls [7]. This might indicate that ITN
use would not lead to sustained reductions in malaria incidence as
the effects of waning immunity become apparent. Fortunately, this
has not been seen the long term follow up of communities
randomized to ITN use in cluster randomized trials [8,9,10],
despite reductions in some antibody responses with ITN use [11].
Although these trials focused on outcomes in under 5 year old
children, the mode of distribution within the clusters was
community wide use. The current practice in most malaria
endemic countries is to target vulnerable groups in distribution
programmes, and this policy may not yield the same long term
results since community-wide ITN use reduces mosquito survival
and infectivity [12], reducing overall transmission [13,14,15].
These reductions in transmission may offset reductions in
immunity, explaining the sustained benefits of ITN use [16].
There are few data on the long term effects of individual ITN
use. In order to examine the long term outcome of ITN use, we
examine the interactions between ITN use and age of the children
in observational data from Kilifi district, Kenya. We compare
residence in villages at lower transmission intensity with the effect
of ITN use.
Methods
Study Design
Ethical approval was obtained from the Kenyan Medical
Research Institute National Ethics Committee, the Central Oxford
ResearchEthicsCommittee,andtheLondonSchoolofHygieneand
Tropical Medicine Ethics Committee. Parents of all children were
approached for written informed consent before research began.
The data presented here were generated during a randomised,
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vaccination to malaria. The details of study design are described
elsewhere [17]. Data from extended follow up are included [18]. All
children were treated with antimalarials at the start of follow up,
using 7 days of directly observed dihydroartemisinin monotherapy
(2 mg per kg on the first day, followed by 1 mg per kg for 6 days).
Subjects were followedupfor a maximumof18 months,anda cross-
sectional venous blood sample was conducted at 3 months.
Location
The study was carried out in Junju sublocation in Kilifi District,
on the Kenyan coast. Junju contains a group of 5 closely related
villages within the Chonyi area of Kilifi district. Kilifi is malaria-
endemic, with all year round transmission and two high
transmission seasons [19]. Transmission intensity is falling in
Kilifi District [20,21], but in Junju sublocation, the parasite
prevalence was 71% in 1–7 year old children at the start of the
study. At the time of the study (2005), the local dispensary sold
subsidised ITNs to parents of young children and pregnant
mothers attending the dispensary. Nationally, this policy had
increased the coverage of ITNs from 7.1% in 2004 (when
commercial retail was the main source of nets) to 23.5%. Shortly
after the end of the study, in 2006, there was a government
initiated mass distribution campaign, which increased ITN
coverage to 67.3% [4].
Participants
The participating children were aged 1–6 years old (inclusive) at
enrolment, healthy, and resident in Junju sublocation, Kilifi
District. They were recruited following public meetings to invite
potential participants.
Follow Up
Children were visited every week by fieldworkers and their
axillary remperature was recorded. When the temperature was
greater than 37.5 degrees, a blood film was made and a rapid
near-patient test for malaria conducted. If the rapid test was
positive, a full course of artmether/lumefantrine was given. Where
the axillary temperature was less than 37.5 degrees, but the
parents reported a fever, the fieldworkers returned three times
over 24hours to take repeated measurements. If the child was
febrile, a blood film and rapid test were taken. Parents could bring
their children for assessment at any time, and the fieldworkers
were resident in the study area. Cross-sectional blood films were
performed on all children after 3 months of follow up.
Bednet use was assessed by fieldworkers visiting the subject’s
home at the beginning of the study, at 4–5 monthly intervals and
at the end of the study. They observed whether the bednet was
hung over the child’s sleeping space, asked whether it had been
recently treated, and examined the number of holes that could
admit a fingertip.
Analysis
Febrile malaria was defined as an axillary temperature greater
than 37.5 degrees centigrade, with a Plasmodium falciparum
parasitemia greater than 2,500 parasites per ml [19]. Children
were considered ITN users if they used ITNs throughout the 18
month period. Non-users were those who did not use an ITN at
the beginning or end of the study. Isolated instances of non-use on
a single visit were ignored if use was consistent before and after,
and vice versa. A sensitivity analysis was conducted to examine the
effect of numbers of holes in the ITNs and inclusion of the children
who acquired or lost ITNs during the period of study.
Subjects came from 5 villages. Transmission intensity for each
village was determined by the rate of first reinfection occurring
over three months monitoring following curative anti-malarial
therapy (including both febrile and asymptomatic infection). Two
villages formed the ‘‘high transmission’’ group (n=207) and the
remaining three villages formed the ‘‘low transmission’’ group
(n=176). Transmission was stratified according to re-infection
rates measured during the three months following curative anti-
malarials, which were 50% and 49% in the two villages in the
‘‘high transmission’’ group, and 39%, 36% and 27% among the
three villages in the low transmission group. The parasite rates
prior to curative anti-malarials were 78% and 69% in the high
transmission group and 65%, 61% and 43% in the low
transmission group [22]. Age was analysed by dividing children
into two equally sized groups. The younger group was 12–42
months of age (n=192) and the older was .42–80 months
(n=191). We reasoned that dividing age into two categories
facilitated an analysis of interactions between age/ITN use and
age/transmission intensity. An analysis using age as a continuous
variable was also conducted for comparison.
Analysis of the 18 month follow up was done using survival models
for the first or only episode of febrile malaria (Cox regression) and on
the total number of episodes (Poisson regression). Analysis of ITN use
wasadjusted byvillage,analysisoftransmission intensity was adjusted
by ITN use, and analysis of the total number of episodes was adjusted
by time at risk. The survival plots were not adjusted.
Further analysis of the first 3 months of follow up was done
using a categorisation of outcome to distinguish immunity from
exposure, as described previously [22]. Children were assigned one
of three categories; febrile malaria (i.e. one or more episode of
febrile malaria during the 3 months), acquiring asymptomatic
infection (i.e. no detected episode of febrile malaria but
asymptomatic parasitaemia was identified as the cross-sectional
bleed after 3 months), or uninfected (no episode of febrile malaria
was identified and the 3 month cross-sectional sample showed no
parasites). Logistic regression models were then fitted for two
comparisons; febrile malaria vs asymptomatic malaria, and any
infection (i.e. febrile plus asymptomatic) vs uninfected status. We
used STATA version 10 (StataCorp, Texas) for all analyses.
Results
There were 355 children with data on ITN use. 102 children
slept under an ITN, 253 did not. 18 children had nets with more
than 3 holes, and 2 had nets with more than 6 holes. 74 children
acquired an ITN during the 18 months of follow up, and 7
children had ITNs that developed more than 3 holes over the 18
months. 6 children lost the use of an ITN during the study. 236
episodes of febrile malaria were reported. Survival plots (Figures 1
and 2), incidence rates (Table 1) and hazard ratios and incidence
rate ratios (Table 2) are shown for this cohort.
The survival plots for time to first or only episode of febrile
malaria (Figures 1 and 2) show that the effect of ITN and village
varies by age group. In younger children, ITNs were protective,
but in older children there was a tendency for more febrile malaria
with ITN use (Figure 1). An analogous pattern was seen for
residence in a low transmission village (Figure 2). In younger
children, transmission intensity had no effect on overall malaria
risk, but in older children lower transmission was associated with a
greater risk of febrile malaria. Thus, the effect of both low
transmission intensity and ITN use was modified in the older age
group in the same direction. (Table 2).
On Cox regression for risk of first event and Poisson regression
for multiple events, the interaction terms for ITN use and older
ITN Use and Age Interactions
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greater than 1. This indicates an antagonistic interaction (i.e. that
the effects of ITN use/low transmission in the older age group
counteracted the protection one would normally expect from
increasing age alone).
Sensitivity Analysis
We examined how sensitive the analysis was to different
definitions of ITN use. If we did not exclude children who
acquired ITNs during the study or whose nets developed more
than 6 holes during the study, the interaction term for survival
analysis gave HR=2.19 (95%CI 0.86–5.6, p=0.10). If the
definition of ITN use was a net with less than 3 holes or less
than 6 holes the interaction terms were HR=2.75 (95%CI 0.95–
7.95, p=0.062) and HR=2.52 (95%CI 0.91–6.98, p=0.075),
respectively. For Poisson analyses of multiple events, without the
exclusions for a change in ITN status and for definitions of use
based on 3 or 6 holes, the interaction terms were IRR=3.02
(95%CI 1.56–5.83, p=0.001), IRR=3.28 (95%CI 1.52–7.04,
p=0.002) and IRR=2.83 (95%CI 1.38–5.80, p=0.004).
When age was used as a continuous variable, the interaction
terms on survival analysis were HR=1.25 per year (95%CI 0.9–
1.7, p=0.16) and 1.55 (1.2–2.1, p=0.003) for the effect of ITN
use and village respectively. The interaction terms on Poisson
analysis for multiple events were IRR=1.2 (95%CI 0.9–1.5,
p=0.19), IRR=1.3(95%CI 1.1–1.6, p=0.012) for ITN use and
village, respectively. However, the goodness of fit by log likelihood
was lower for age as a continuous variable compared with age as a
categorical variable (log likelihood=2603.3 vs 2601.6 for Cox
regression and log likelihood=2401.3 vs 2400.8 for Poisson
regression). Furthermore, the residuals were unevenly distributed
for age as a continuous variable (p=0.001). Because of this non-
linear effect of age on malaria risk, we preferred analyses that used
age as a categorical variable (as given above).
An Analysis to Distinguish Exposure and Immunity
In order to examine the contributions of exposure and
immunity to the altered effect of ITNs and transmission intensity,
we examined odds ratios for febrile malaria versus asymptomatic
Figure 1. Survival plot of time to first episode of febrile malaria
(.2,500 parasites per ml). Children are divided by age (in two
categories) and by ITN use. P,0.0001 by logrank.
doi:10.1371/journal.pone.0008321.g001
Figure 2. Survival plot of time to first episode of febrile malaria
(.2,500 parasites per ml). Children are divided by age (in two
categories) and by residence (in two transmission zones). P,0.0001 by
logrank.
doi:10.1371/journal.pone.0008321.g002
Table 1. The incidence rates of febrile malaria by age and ITN
use.
Category Incidence 95%CI
Child Years of
observation
Young non ITN users 0.51 0.39–0.67 101.6
Young ITN users 0.27 0.17–0.43 63.14
Old non ITN users 0.17 0.12–0.25 157.4
Old ITN users 0.22 0.12–0.38 55.3
Young high trans 0.41 0.30–0.57 87.4
Young low trans 0.43 0.30–0.60 77.4
Old high trans 0.08 0.05–0.15 134.4
Old low trans 0.37 0.26–0.53 81
doi:10.1371/journal.pone.0008321.t001
Table 2. The effect of ITN use and residence at low
transmission intensity on risk of febrile malaria, and the
interactions with age group.
Category n Survival analaysis Multiple events
HR 95% CI p IRR 95% CI p
Younger age 137 1 1
Older age 138 0.3 0.17–0.51 ,0.001 0.23 0.13–0.42 ,0.001
No ITN 179 1 1
ITN use 96 0.33 0.17–0.65 0.001 0.43 0.27–0.7 ,0.001
ITN use*Older – 2.91 1.02–8.3 0.045 2.72 1.3–5.7 0.008
High Trans. 160 1 1
Low trans. 115 1.34 0.8–2.3 0.31 1.31 0.9–1.9 0.17
Low
trans*Older
– 3.1 1.2–8.5 0.025 2.23 1.1–4.5 0.023
Hazard ratios (HR) from Cox regression and incidence rate ratios (IRR) from
Poisson regression are shown for survival and multiple event analyses,
respectively. Children are divided into equal groups of younger (12–42 months)
and older (42–80 months) children. The interaction term for ITN use and older
age is shown by *. (i.e. the HR/IRR for what was observed in older children using
ITNs compared with what would have been predicted for the additive effect of
ITN use and older age).
doi:10.1371/journal.pone.0008321.t002
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febrile malaria compared with asymptomatic parasitaemia. The
significant interaction terms demonstrate that the effects of ITN
use and of low transmission intensity on febrile malaria vs
asymptomatic parasitaemia varied by age. By contrast, ITN use
and low transmission intensity are associated with a reduced risk of
infection (i.e. combining asymptomatic parasitaemia and febrile
malaria) compared with uninfected status, and this effect did not
vary by age. Hence, the protective effect of ITN use or low
transmission intensity against infection per se did not vary by age,
but the risk that infection is associated with a febrile episode did.
Discussion
We show that residence in a village at lower transmission
intensity results in a relative increase in the risk of febrile malaria
in older children. This is consistent with previous comparisons of
different regions and countries within Sub-Saharan Africa [6,7],
and the pattern of severe disease seen at different altitudes [23].
The obvious conclusion might be that ITN use would have the
same effect, so causing concern about the overall outcome of ITN
distribution programmes. In vitro markers of blood stage
immunity are reduced in some [24], but not all [11], studies
comparing ITN users with non-users. Children on prolonged
chemoprophylaxis for malaria have reduced immunity to malaria,
and consequently higher rates of febrile malaria over long term
follow up [25]. Our data showing that ITN use reduced febrile
malaria risk in younger but not older children is consistent with
older children having used ITNs when they were younger, and
therefore having acquired less immunity.
However, our data should not be interpreted in isolation. Long
term follow up following randomized trials of ITN use have
consistently shown sustained reductions in morbidity and mortality
[8,9,10]. In these trials, geographical clusters were randomized to
community wide distribution of ITNs. The use of ITNs in this way
reduces overall transmission by reducing the survival and
infectivity of mosquitoes [12], and mathematical models suggest
falling transmission counteracts the effects of reduced immunity
[16]. Other models suggest that where a minority of the
community uses ITNs, there is little overall fall in transmission
[26]. Among the children we studied, only a minority used ITNs
(in contrast to the situation following community wide distribu-
tion). Hence, falling overall transmission may not have been
present to oppose the effects of reduced immunity in older
children. Hence, our data do not contradict those showing
continued reductions in malaria rates continue to fall following
community wide distribution. Rather, they reinforce the benefits
of community wide ITN distribution over targeting vulnerable
groups.
Our study was observational, and competing explanations for
the apparent reduction in efficacy of ITNs in older children should
be considered: First, parents of older children might buy ITNs if
they notice their child is at high risk of malaria, but parents of
younger children have not yet noticed that their child is at high
risk. Hence the child’s risk determines ITN use in older children,
but not in younger. This seems unlikely since there was no
evidence that ITN use was significantly more common among
older children in the higher transmission villages (29% compared
with 28% in low transmission villages, p=0.17), and ITN use did
not increase among older children (26% compared with 31% in
younger children).
Second, we have assumed that the older ITN users were long-
term ITN users. Therefore, an increased risk of malaria can be
explained by having not acquired immunity during a prolonged
period of ITN use. In fact, some older children may have recently
started using an ITN. This would not explain our results, however,
since we would predict that older children who recently acquired
an ITN would have the immunity of non-users, but the lowered
exposure of an ITN user, and hence much lower than expected
rates of malaria. Hence, this would increase the apparent
protective efficacy of an ITN. Conversely, it is possible that some
older ITN non-users were previous ITN users, but passed the
ITNs on to younger siblings. We would predict that such children
would have the lower immunity of ITN users, but the higher
exposure of ITN non-users, and much higher rates of malaria.
Hence, this would also increase the apparent protective efficacy of
an ITN. As it happened, we found higher than expected rates of
malaria among older children who were ITN users.
Third, it is possible that the recently distributed ITNs were of
better quality than those distributed several years previously.
However, the state of repair of the ITNs was documented by
fieldworker visits, and was generally good. Furthermore, the results
were not sensitive to definitions of ITN use based on number of
holes observed in the net. The pattern of HR and IRRs was
similar with the varying definitions. Significance was variable on
survival analysis, but consistent for multiple episodes.
Fourth, it may be that ITNs are less effective in older children
because of behavioural differences (e.g. they go to sleep later, after
being bitten by mosquitoes). Studies in Cambodia have suggested
that older children are not protected when randomized to ITN use
[27]. However, the Anopheles dirus complex of South East Asia bites
earlier in the evening than the common African vectors [28], and
interactions between ITN use and age have not previously been
seen in children in Africa recently randomized to ITNs [29,30]. In
fact, efficacy of ITNs among adolescents [31] and adults [32] in
Africa has been described.
Fifth, use of ITNs by other homestead members is protective. If
use by other homestead members was associated with the age of
the ITN using child, this could explain our results. However, the
Table 3. Logistic models to examine the effect of ITN use and
transmission intensity on the category of malaria infection,
and their interactions with age.
Febrile vs. Asymptomatic Infected vs. uninfected
nO R C I p nO R C I p
Younger
Age
74 1 179 1
Older Age 77 0.08 0.02–0.25 ,0.001 180 0.62 0.3–1.1 0.13
No ITN 118 1 262 1
ITN use 32 0.26 0.08–0.88 0.031 94 0.52 0.3–1.1 0.07
ITN use*
Old
6.5 1.1–38 0.04 – 1.6 0.6–4.4 0.35
High trans 96 1 194 1
Low trans. 55 2.2 0.75–6.6 0.15 165 0.32 0.2–0.6 ,0.001
Low trans*
Old
– 4.2 0.85–20.1 0.08 – 2.5 1.0–5.9 0.043
Odds ratios (OR) from logistic regression are shown, for the risk of febrile
malaria compared with asymptomatic infection, and then for the risk of any
malaria infection (i.e. asymptomatic infection or febrile malaria) with uninfected
status. Children are divided into equal groups of younger (12–42 months) and
older (42–80 months) children. The ORs are shown for the effect of ITN use
according among the younger and then older children separately, and then the
interaction term for ITN use and older age is shown by *. The same format is
then used for the effect of residence at low transmission intensity (Low trans.).
doi:10.1371/journal.pone.0008321.t003
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and younger children, so this explanation is unlikely. Finally, it is
unclear what effect clearing infection at the start of the study may
have had. It is possible the chronic parasitaemia helps to maintain
immunity (i.e. premunition), but there was no evidence of an early
increase in malaria cases among older children in the survival
plots. In any case, it is not obvious how the effect of clearing
parasites could be different for older ITN users compared with
younger ITN users.
Other studies have demonstrated that ITNs protect against
parasitaemia in all age groups [33]. Here, we have described a
reduced efficacy of ITNs in older children for febrile episodes.
When we analysed asymptomatic parasitaemia as well as febrile
episodes, we found that ITN use continued to protect against
malaria infection per se in older children, but was associated with a
shift from asymptomatic parasitaemia to febrile malaria in older
children.Takentogether,thissuggeststhatITNscontinuetoprotect
against mosquito bites, but are associated with a higher likelihood
that parasitisation will cause fever in older children. This conclusion
fits well with other epidemiological observations [6,7,23] and our
current understanding of blood stage immunity [25,34].
Policy may move towards community wide ITN distribution
programmes rather than continue targeting vulnerable popula-
tions, to ensure that reduced transmission offsets reductions in host
immunity [16]. However, if the policy of targeted distribution for
under 5 year old children continues, then large scale, long term
studies should monitor the outcomes in terms of individual
susceptibility.
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